Recombinant Mycoplasma pneumoniae UPF0134 protein MPN_094 (MPN_094)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Mycoplasma pneumoniae UPF0134 Protein MPN_094

The Recombinant Mycoplasma pneumoniae UPF0134 Protein MPN_094 (MPN_094) is a hypothetical protein expressed in Mycoplasma pneumoniae, a pathogenic bacterium responsible for respiratory infections such as atypical pneumonia. This recombinant protein is part of the UPF0134 family, a group of uncharacterized proteins with diverse genomic roles in M. pneumoniae . MPN_094 is produced using recombinant DNA technology in hosts such as Escherichia coli, yeast, or mammalian cells, achieving ≥85% purity via SDS-PAGE .

Genomic Context and Repetitive Element Associations

MPN_094 is encoded by the MPN_094 gene, which is linked to RepMP1, a repetitive DNA element involved in homologous recombination. Key genomic insights include:

  • RepMP1-mediated recombination: MPN_094 shares sequence homology with MPN130, a RepMP1-containing protein. A peptide spanning residues 79–94 of MPN130 matches identical regions in MPN_094 and MPN524, suggesting recombination-driven sequence exchange .

  • Functional implications: RepMP elements facilitate antigenic variation and immune evasion by enabling gene conversion events. MPN_094’s association with RepMP1 highlights its potential role in genomic plasticity .

Biochemical Characteristics

PropertyDetails
Gene NameMPN_094
Alternative NamesHypothetical protein MPN094
Host SystemsE. coli, yeast, baculovirus, mammalian cells
Purity≥85% (SDS-PAGE verified)
Molecular WeightNot explicitly reported; inferred from gene length (~15–20 kDa)
Structural FeaturesContains leucine zipper motifs (predicted)

Table 1: Biochemical and production details of recombinant MPN_094 .

Role in Genomic Plasticity

MPN_094 is implicated in RepMP1-mediated recombination, a process critical for generating sequence diversity in M. pneumoniae adhesins (e.g., P1 protein) . For example:

  • Clinical strain S1 exhibits a fused MPN137-MPN138 protein due to RepMP1 recombination, with MPN_094 contributing sequence fragments to this event .

  • Such recombination may enable immune evasion by altering surface-exposed epitopes .

Interaction with Recombination Machinery

  • RecA homologs: The recombinase RecA (encoded by MPN490) facilitates RepMP-mediated recombination. MPN_094’s repetitive sequences serve as substrates for RecA-driven homologous recombination .

  • ATP and Mg²⁺ dependence: RecA activity on RepMP elements requires ATP and Mg²⁺, aligning with MPN_094’s potential role in recombination .

Comparative Genomic Analysis

  • Conservation: MPN_094 is conserved across M. pneumoniae strains, but sequence variations in RepMP1 regions (e.g., leucine zipper motifs) suggest strain-specific adaptations .

  • Epidemiological relevance: RepMP1 recombination events involving MPN_094 correlate with outbreaks of respiratory infections, underscoring its clinical significance .

Research Gaps and Future Directions

  • Functional characterization: MPN_094 remains classified as a hypothetical protein. Structural studies (e.g., crystallography) are needed to elucidate its molecular function .

  • Pathogenic mechanisms: Its interaction with host immune receptors (e.g., NOD2) or role in cytotoxicity remains unexplored .

Product Specs

Form
Lyophilized powder. We will ship the available format, but if you have special requirements, please note them when ordering.
Lead Time
Delivery time varies by purchase method and location. Contact your local distributor for specifics. All proteins ship with blue ice packs. For dry ice shipment, contact us in advance; extra fees apply.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag type requirement, please inform us.
Synonyms
MPN_094; MP060; R02_orf140; UPF0134 protein MPN_094
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-140
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Mycoplasma pneumoniae (strain ATCC 29342 / M129)
Target Names
MPN_094
Target Protein Sequence
MKEKIPFYNE KEFHDMMKKT KKGTFSGWYI IDKDNKSVEF SGNFNRQFKL NKPVIPVNTE YVTRKEFNEY KDSNDQRLTK IETTLAAQGE QIRIQGEQIK ELQIEQKAQG ETLKLILQTL QKMSDRLNKM DVRLDKLESK
Uniprot No.

Q&A

What is UPF0134 protein MPN_094 and how is it classified?

MPN_094 (also known as R02_orf140) is a member of the UPF0134 protein family found in Mycoplasma pneumoniae. It is classified as a "hypothetical protein" because its precise biological function remains to be fully characterized through experimental validation. The UPF (Uncharacterized Protein Family) designation indicates that while the protein's sequence is known, its three-dimensional structure, biochemical functions, and biological roles require further investigation. Recombinant forms of this protein are produced using various expression systems including bacterial (E. coli), yeast, baculovirus, and mammalian cell systems, with a typical purity of ≥85% as determined by SDS-PAGE analysis .

What genomic context surrounds the MPN_094 gene in M. pneumoniae?

The MPN_094 gene is one of several UPF0134 family members in the Mycoplasma pneumoniae genome. While the search results don't provide specific genomic context, it's worth noting that M. pneumoniae contains multiple UPF0134 family proteins including MPN_010, MPN_013, MPN_038, MPN_094, MPN_100, MPN_104, and others . Research methodologies to study genomic context typically involve comparative genomic analysis across multiple Mycoplasma species to identify conserved gene neighborhoods and potential operon structures. Such analysis can provide insights into functional relationships and evolutionary history.

How do researchers differentiate MPN_094 from other UPF0134 family proteins?

Differentiation between MPN_094 and other UPF0134 family proteins requires multiple analytical approaches. The primary distinction is based on gene sequence and the resulting amino acid sequence. Additional differentiation methods include:

  • Sequence alignment analysis to identify unique regions

  • Epitope mapping for generating specific antibodies

  • Mass spectrometry for peptide fingerprinting

  • Unique post-translational modifications

  • Differential expression patterns

When designing experiments, researchers should incorporate appropriate controls using other UPF0134 family members (such as MPN_138, MPN_137, etc.) to ensure specificity of their observations to MPN_094 .

What expression systems are most effective for producing recombinant MPN_094?

Multiple expression systems can be employed for recombinant MPN_094 production, each with distinct advantages depending on research objectives:

Expression SystemAdvantagesLimitationsTypical Yield
E. coliHigh yield, cost-effective, rapid growthPotential inclusion body formation, limited post-translational modifications10-50 mg/L
YeastMore complex post-translational modifications, secretion possibleLonger production time, hyperglycosylation risk5-20 mg/L
BaculovirusMammalian-like post-translational modifications, good for complex proteinsTechnical complexity, higher cost1-10 mg/L
Mammalian CellMost authentic post-translational modificationsHighest cost, lowest yield, time-consuming0.5-5 mg/L

The choice should be guided by experimental requirements. For basic structural studies, E. coli may be sufficient, while functional studies might require mammalian cell expression. All systems can achieve ≥85% purity as determined by SDS-PAGE , though additional purification steps may be necessary depending on the application.

What experimental controls are essential when studying MPN_094 function?

Proper experimental design for studying MPN_094 requires multiple controls to ensure valid interpretations:

  • Negative controls:

    • Empty vector-transformed cells

    • Irrelevant protein of similar size (non-UPF0134)

    • Buffer-only treatments

  • Positive controls:

    • Well-characterized UPF0134 family proteins (e.g., MPN_137)

    • Known interacting proteins if studying protein-protein interactions

  • Validation controls:

    • Multiple expression clones

    • Different tags (N-terminal vs. C-terminal)

    • Tag-free protein preparations

How should researchers approach experimental design when investigating protein-protein interactions involving MPN_094?

When investigating protein-protein interactions of MPN_094, a multi-method approach is recommended:

  • Primary screening methods:

    • Yeast two-hybrid assays

    • Co-immunoprecipitation

    • Pull-down assays

  • Validation methods:

    • Surface plasmon resonance (SPR)

    • Isothermal titration calorimetry (ITC)

    • FRET/BRET assays

  • Structural confirmation:

    • X-ray crystallography of complexes

    • Cryo-EM studies

    • NMR for dynamic interaction studies

Experimental designs should incorporate appropriate controls including non-interacting proteins, competing peptides, and point mutants. Based on experimental design principles from Campbell and Stanley, researchers should employ randomization in treatment assignment where possible, include multiple pre-tests and post-tests, and consider using Solomon four-group design for controlling testing effects .

What structural biology techniques are most informative for characterizing MPN_094?

A comprehensive structural characterization of MPN_094 requires multiple complementary techniques:

For MPN_094, which is likely a small to medium-sized protein, a combination of X-ray crystallography and NMR would provide the most complete structural information. Starting with recombinant protein of ≥85% purity , additional purification steps such as size exclusion chromatography would be required to achieve the higher purity needed for structural studies.

How can researchers effectively study post-translational modifications of MPN_094?

Investigation of post-translational modifications (PTMs) in MPN_094 requires a systematic approach:

  • Prediction and targeting:

    • In silico prediction of potential modification sites

    • Selection of appropriate expression system based on expected PTMs

  • Detection and mapping:

    • Mass spectrometry (MS/MS) analysis of tryptic digests

    • Site-specific antibodies for common PTMs

    • Chemical labeling strategies for specific modifications

  • Functional significance:

    • Site-directed mutagenesis of modified residues

    • Comparison of modified vs. unmodified protein activity

    • Temporal analysis of modification during cellular processes

Since PTMs may differ between native and recombinant proteins, researchers should consider using mammalian expression systems when studying PTMs of MPN_094, as these systems more closely recapitulate the native modification patterns than bacterial systems .

What computational approaches facilitate functional prediction for MPN_094?

Given that MPN_094 is a hypothetical protein , computational approaches are valuable for generating functional hypotheses:

  • Sequence-based methods:

    • Homology detection through PSI-BLAST and HHpred

    • Motif identification using PROSITE and InterPro

    • Conservation analysis across Mycoplasma species

  • Structure-based methods:

    • Ab initio modeling using Rosetta or AlphaFold

    • Structure-based function prediction (ProFunc, COFACTOR)

    • Molecular docking with potential ligands

  • Systems biology approaches:

    • Gene neighborhood analysis

    • Co-expression network construction

    • Protein-protein interaction prediction

  • Validation design:

    • Design of experiments to test predicted functions

    • Prioritization of hypotheses based on confidence scores

    • Integration of multiple prediction methods

These computational predictions should guide experimental design but not replace empirical validation. The experimental designs should be constructed to test specific hypotheses about protein function while controlling for potential confounding variables as outlined in standard experimental methodology .

How should researchers approach contradictory results in MPN_094 studies?

When faced with contradictory results in MPN_094 research, a systematic troubleshooting approach is essential:

  • Methodological assessment:

    • Evaluate differences in experimental protocols

    • Consider protein tags and their potential interference

    • Assess purity levels and potential contaminants

    • Examine expression systems used (E. coli vs. mammalian cells)

  • Controlled reproducibility studies:

    • Design experiments specifically to address contradictions

    • Use multiple methodological approaches in parallel

    • Implement blinded analysis where possible

  • Statistical analysis framework:

    • Conduct meta-analysis of available data

    • Implement Bayesian approaches to integrate prior knowledge

    • Calculate effect sizes rather than relying solely on p-values

  • Reporting recommendations:

    • Transparently report all experimental conditions

    • Share raw data and analysis scripts

    • Explicitly discuss limitations and alternative interpretations

This approach aligns with Campbell and Stanley's framework for addressing threats to experimental validity, particularly instrumentation and testing effects that might lead to apparent contradictions.

What statistical approaches are recommended for analyzing protein-protein interaction data involving MPN_094?

Statistical analysis of protein-protein interactions requires specialized approaches:

Interaction AssayRecommended Statistical AnalysisKey ParametersValidation Approach
Co-IP/Pull-downFold enrichment, t-tests for replicated experimentsSignal-to-noise ratio, specificity controlsWestern blot quantification
Y2HFisher's exact test for interaction frequenciesFalse positive rate, autoactivation controlsOrthogonal confirmation
SPR/ITCNon-linear regression for binding constantsKd, kon/koff, stoichiometryResidual analysis, replicate measurements
FRET/BRETANOVA with multiple comparisonsEnergy transfer efficiency, donor/acceptor ratioDistance controls, competition assays

For all analyses, researchers should:

  • Establish clear null hypotheses

  • Determine appropriate sample sizes through power analysis

  • Apply multiple testing corrections when screening numerous interactions

  • Consider Bayesian approaches to incorporate prior knowledge

This statistical framework helps researchers avoid common pitfalls in interaction data interpretation while maintaining rigor in experimental design, following established principles of scientific methodology .

How can researchers effectively integrate structural and functional data for MPN_094?

Integrating structural and functional data requires a multi-layered approach:

  • Structure-function mapping:

    • Correlate structural features with functional domains

    • Identify conserved regions across UPF0134 family proteins

    • Map interaction interfaces using mutagenesis data

  • Integrative modeling techniques:

    • Combine low and high-resolution structural data

    • Incorporate dynamics from multiple sources

    • Develop testable models of protein mechanism

  • Visualization and communication:

    • Create integrated visualizations linking structure and function

    • Develop consistent terminology across structural and functional studies

    • Present data in standardized formats for cross-study comparison

  • Validation framework:

    • Design experiments that specifically test structure-function relationships

    • Use orthogonal methods to confirm key findings

    • Apply statistical approaches appropriate for integrated datasets

This integrative approach maximizes the value of recombinant MPN_094 preparations while adhering to rigorous experimental design principles that control for validity threats .

How can MPN_094 research contribute to understanding minimal genome concepts?

Mycoplasma pneumoniae possesses one of the smallest genomes among free-living organisms, making its proteins, including MPN_094, valuable for minimal genome research:

  • Essential gene identification:

    • Determine if MPN_094 is essential through gene knockout/knockdown

    • Analyze conservation across Mycoplasma species with different genome sizes

    • Assess functional redundancy with other UPF0134 proteins

  • Minimal functional domain mapping:

    • Identify the minimal functional domains of MPN_094

    • Determine which structural elements are dispensable

    • Engineer minimal versions that retain function

  • Synthetic biology applications:

    • Assess MPN_094's role in minimal cell designs

    • Determine interaction dependencies in simplified systems

    • Evaluate potential for orthogonal biological systems

  • Evolutionary insights:

    • Analyze selective pressures on MPN_094

    • Compare with homologs in organisms with larger genomes

    • Reconstruct the evolutionary history of functional acquisition/loss

Such research requires carefully designed experimental approaches that control for history effects, maturation, and other validity threats as outlined in experimental design literature .

What are the challenges in developing specific antibodies against MPN_094?

Developing specific antibodies against MPN_094 presents several challenges due to its nature as a hypothetical protein:

  • Epitope selection considerations:

    • Bioinformatic prediction of exposed regions

    • Avoiding cross-reactivity with other UPF0134 family proteins

    • Balancing immunogenicity with specificity

  • Production strategies:

    • Monoclonal vs. polyclonal approaches

    • Full protein vs. peptide immunization

    • Native vs. denatured protein considerations

  • Validation requirements:

    • Cross-adsorption against other UPF0134 proteins

    • Testing against knockout/knockdown samples

    • Multiple detection methods (Western, IP, IHC)

  • Specificity optimization:

    • Affinity purification against recombinant MPN_094

    • Negative selection against homologous proteins

    • Isotype selection for specific applications

Using highly purified recombinant MPN_094 as starting material and applying rigorous experimental designs with appropriate controls will maximize the likelihood of generating specific and useful antibodies.

How should researchers design experiments to elucidate the role of MPN_094 in Mycoplasma pneumoniae pathogenicity?

Investigating MPN_094's potential role in pathogenicity requires a multi-faceted experimental approach:

Experimental ApproachKey MethodsControlsExpected Outcomes
Gene Knockout/KnockdownCRISPR/Cas9, Antisense RNAComplementation strains, Off-target controlsViability, growth rate, morphology changes
Host-Pathogen InteractionAdhesion assays, Invasion assaysOther UPF0134 proteins, Known virulence factorsQuantitative measures of host cell interaction
Immune ResponseCytokine profiling, Inflammasome activationHeat-inactivated protein, Tag-only controlsInflammatory response signature
In vivo ModelsAnimal infection models, Competitive indexMixed infections, Attenuated strainsColonization ability, persistence

The experimental design should follow Campbell and Stanley's principles , incorporating:

  • Randomized assignment where possible

  • Multiple pre-test and post-test measurements

  • Control groups appropriate for each hypothesis

  • Consideration of interaction effects between variables

This comprehensive approach will help distinguish the specific contribution of MPN_094 from other bacterial factors and control for potential confounding variables.

What are the most promising future research directions for MPN_094?

Based on current knowledge of UPF0134 proteins in Mycoplasma pneumoniae, several promising research directions emerge:

  • Structural genomics initiatives:

    • High-resolution structure determination

    • Structure-based function prediction

    • Comparison with other UPF0134 family members

  • Systems biology approaches:

    • Integration into protein-protein interaction networks

    • Metabolic pathway mapping

    • Temporal expression analysis during infection

  • Translational applications:

    • Assessment as diagnostic biomarker

    • Evaluation as vaccine component

    • Drug target potential analysis

  • Evolutionary biology:

    • Horizontal gene transfer assessment

    • Selective pressure analysis

    • Functional adaptation studies

How can researchers effectively collaborate across disciplines to advance MPN_094 understanding?

Interdisciplinary collaboration is essential for comprehensive characterization of hypothetical proteins like MPN_094:

  • Collaborative framework development:

    • Establish common terminology and research questions

    • Define complementary methodological approaches

    • Create data sharing platforms and protocols

  • Integrated experimental design:

    • Design experiments that simultaneously address multiple hypotheses

    • Implement parallel approaches from different disciplines

    • Develop validation strategies across methodologies

  • Analytical integration:

    • Computational methods to integrate heterogeneous data types

    • Statistical approaches for meta-analysis

    • Machine learning to identify patterns across datasets

  • Communication strategies:

    • Regular interdisciplinary meetings

    • Shared authorship and credit allocation

    • Translation of discipline-specific concepts

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.